GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stallergenes Greer PLC (GREY:STLLF) » Definitions » Other Income (Expense)

Stallergenes Greer (Stallergenes Greer) Other Income (Expense) : $0.00 Mil (TTM As of Dec. 2018)


View and export this data going back to 2013. Start your Free Trial

What is Stallergenes Greer Other Income (Expense)?

Stallergenes Greer's other income expense for the Stallergenes Greer's pretax income for the six months ended in Dec. 2018 was $0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2018 was $0.00 Mil.


Stallergenes Greer Other Income (Expense) Historical Data

The historical data trend for Stallergenes Greer's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stallergenes Greer Other Income (Expense) Chart

Stallergenes Greer Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 - - - -

Stallergenes Greer Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Stallergenes Greer Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stallergenes Greer  (GREY:STLLF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Stallergenes Greer (Stallergenes Greer) Business Description

Traded in Other Exchanges
N/A
Address
40 Bernard Street, 3rd Floor, London, GBR, WC1N 1LE
Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.

Stallergenes Greer (Stallergenes Greer) Headlines

No Headlines